Evaluation of the Isocult diagnostic culturing system.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to B Romanowski.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
This prospective study was carried out to determine the seroprevalence and to examine the sexual determinants of hepatitis B virus in a Sexually Transmitted Disease (STD) Clinic population. 217 men and 81 women were entered. The overall prevalence of hepatitis B markers was 7.7%. Women with more than ten lifetime sexual partners were twice as likely to have been exposed to hepatitis B (OR 1.9). Both men and women who had been sexually active for more than seven years were two to three times as likely to have been in contact with hepatitis B (OR 2.2 (men), 3.1 (women)). Injection drug use was also associated with hepatitis B infection (OR 4.69). There was no association between hepatitis B infection and type of sexual contact. The presence of an STD was associated with an increased prevalence of hepatitis B virus infection. This population should be considered for hepatitis B vaccination.